EFFECT OF A CO-STIMULATORY ENDODOMAIN ON THE PERFORMANCE OF T CELLS EXPRESSING A CHIMERIC ANTIGEN RECEPTOR DIRECTED AT CD19 IN PATIENTS WITH RELAPSED/REFRACTORY B-CELL MALIGNANCIES

被引：1
|
作者：
Ramos, C. A. [1 ]
Savoldo, B. [1 ]
Liu, E. [1 ]
Bollard, C. M. [1 ]
Carrum, G. [1 ]
Kamble, R. T. [1 ]
Mims, M. P. [1 ]
Keating, M. [2 ]
Gee, A. P. [1 ]
Mei, Z. [1 ]
Rooney, C. M. [1 ]
Heslop, H. E. [1 ]
Brenner, M. K. [1 ]
Dotti, G. [1 ]
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2011年 / 17卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2010.12.186
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
163
引用
收藏
页码：S213 / S214
页数：2
相关论文
共 50 条
  • [31] Safety and efficacy of a humanized CD19 chimeric antigen receptor T cells for relapsed/refractory acute lymphoblastic leukemia
    Shi, Ming
    Li, Li
    Wang, Shiyuan
    Cheng, Hai
    Chen, Wei
    Sang, Wei
    Qi, Kunming
    Li, Zhenyu
    Wang, Gang
    Li, Huizhong
    Lan, Jianping
    Huang, Jinqi
    Fei, Xiaoming
    Yu, Min
    Li, Fei
    Qiao, Jianlin
    Wu, Qingyun
    Zeng, Lingyu
    Jing, Guangjun
    Zheng, Junnian
    Gale, Robert Peter
    Xu, Kailin
    Cao, Jiang
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (06) : 711 - 718
  • [32] Chimeric antigen receptor T-cells for B-cell malignancies
    Lichtman, Eben I.
    Dotti, Gianpietro
    TRANSLATIONAL RESEARCH, 2017, 187 : 59 - 82
  • [33] Phase IIa trial of chimeric antigen receptor modified T cells directed against CD19 (CTL019) in patients with relapsed or refractory CD19+lymphomas.
    Schuster, Stephen J.
    Svoboda, Jakub
    Nasta, Sunita
    Porter, David L.
    Mato, Anthony
    Shah, Gaurav D.
    Landsburg, Daniel Jeffrey
    Chong, Elise A.
    Lacey, Simon F.
    Melenhorst, Jan J.
    Chew, Anne
    Hasskarl, Jens
    Shah, Nirav Niranjan
    Wasik, Mariusz A.
    Marcucci, Katherine
    Zheng, Zhaohui
    Levine, Bruce
    June, Carl H.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [34] Axicabtagene Ciloleucel CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma: Real World Experience
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (02) : 13 - 15
  • [35] Prophylactic Tocilizumab in Patients with Relapsed Refractory Lymphoma Treated with Anti CD19 Chimeric Antigen Receptor T-Cell Therapy
    Ahmed, Nausheen
    Caimi, Paolo
    Reese, Jane S.
    Otegbeye, Folashade
    Patel, Seema
    Schneider, Dina
    Boughan, Kirsten M.
    Cooper, Brenda
    Gallogly, Molly
    Kruger, Winfred
    Worden, Andrew
    Kadan, Michael
    Lopes, Filipa Blasco Tavares Pereira
    Sharma, Ashish
    Malek, Ehsan
    Metheny, Leland
    Tomlinson, Benjamin
    Wald, David
    Sekaly, Rafick-Pierre
    Orentas, Rimas
    Dropulic, Boro
    de Lima, Marcos
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S275 - S276
  • [36] Bispecific targeting of CD20 and CD19 increases polyfunctionality of chimeric antigen receptor T-cell products in B-cell malignancies
    Zurko, Joanna C.
    Xu, Huiqing
    Chaney, Katherine
    Schneider, Dina
    Szabo, Aniko
    Hari, Parameswaran
    Johnson, Bryon D.
    Shah, Nirav N.
    CYTOTHERAPY, 2022, 24 (08) : 767 - 773
  • [37] Cellular Kinetics of CD19 Chimeric Antigen Receptor T Cells in Patients with Relapsed/Refractory Non-Hodgkin's Lymphoma
    Li, Caixia
    Zhang, Changfeng
    Zhang, Ying
    Lou, Xiaoyan
    Zhang, Jinfang
    Chen, Jia
    Chen, Xiaochen
    Kang, Liqing
    Zhou, Jin
    Zong, Xiangping
    Yang, Zhen
    Li, Jiaqi
    Qi, Wei
    Yu, Lei
    Wu, Depei
    BLOOD, 2019, 134
  • [38] CD19 chimeric antigen receptor-T cells in B-cell leukemia and lymphoma: current status and perspectives
    Mohamad Mohty
    Jordan Gautier
    Florent Malard
    Mahmoud Aljurf
    Ali Bazarbachi
    Christian Chabannon
    Mohamed A. Kharfan-Dabaja
    Bipin N. Savani
    He Huang
    Saad Kenderian
    Arnon Nagler
    Miguel-Angel Perales
    Leukemia, 2019, 33 : 2767 - 2778
  • [39] CD19 chimeric antigen receptor-T cells in B-cell leukemia and lymphoma: current status and perspectives
    Mohty, Mohamad
    Gautier, Jordan
    Malard, Florent
    Aljurf, Mahmoud
    Bazarbachi, Ali
    Chabannon, Christian
    Kharfan-Dabaja, Mohamed A.
    Savani, Bipin N.
    Huang, He
    Kenderian, Saad
    Nagler, Arnon
    Perales, Miguel-Angel
    LEUKEMIA, 2019, 33 (12) : 2767 - 2778
  • [40] CD19/CD22 Chimeric Antigen Receptor T Cell Cocktail Therapy following Autologous Transplantation in Patients with Relapsed/Refractory Aggressive B Cell Lymphomas
    Cao, Yang
    Xiao, Yi
    Wang, Na
    Wang, Gaoxiang
    Huang, Liang
    Hong, Zhenya
    Meng, Li
    Zhou, Xiaoxi
    Wang, Jue
    Yang, Yang
    Xu, Hao
    Zhang, Shangkun
    Xiao, Min
    Chen, Liting
    Zheng, Miao
    Li, Chunrui
    Mao, Xia
    Gu, Chaojiang
    Zhang, Tongcun
    Zhang, Yicheng
    Zhou, Jianfeng
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (11): : 910.e1 - 910.e11
12345